Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826
National Cancer Institute (NCI)
Sharon M Castellino; Hongli Li; Alex F Herrera; Michael LeBlanc; Susan K Parsons; Joseph M Unger; Angela Punnett; David Hodgson; Frank G Keller; Richard A Drachtman; Adam Lamble; Christopher J Forlenza; Andrew Doan; Sarah C Rutherford; Andrew M Evens; Richard F Little; Malcolm A Smith; Bradford S Hoppe; Joo Y Song; Sonali M Smith; Jonathan W Friedberg; Kara M Kelly
SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA. ; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA.